Whitehawk Therapeutics, Inc. - 8-K Filing
Whitehawk Therapeutics entered into a $87.5 million PIPE financing on May 12, 2026, selling 4,330,866 shares at $3.92 per share and 17,991,021 pre-funded warrants at $3.9199 each. The deal is expected to close on May 14, 2026, with Jefferies LLC and other firms acting as placement agents. Executives and directors committed to purchasing $39.75 million of the securities. (Items: 1.01 Entry into a Material Definitive Agreement Securities Purchase Agreement On May 12, 2026, Whitehawk Therapeutics, Inc, 3.02 Unregistered Sales of Equity Securities The information in Item 1, 7.01 Regulation FD Disclosure On May 13, 2026, the Company issued a press release announcing the execution of the Purchase Agreement and the PIPE, 9.01 Financial Statements and Exhibits)
Tickers: $WHWK